Presentation Information
[O-31-6]Effect of Donanemab on ARIA-E and Amyloid Lowering in Early Symptomatic Alzheimer's Disease
Taka Matsumura1, Shoichiro Sato1, Hong Wang2, Emel Serap Monkul Nery2, Paul Ardayfio2, Rashna Khanna2, Diana Otero Svaldi2, Paula Hauck2, Sergey Shcherbinin2, Dawn A. Brooks2, Emily C. Collins2, Mark A. Mintun2, John R. Sims2 (1.Eli Lilly Japan K.K., Japan, 2.Eli Lilly and Company, USA)